Q: What is Peramivir used for?

Peramivir is used to treat acute uncomplicated influenza .

Q: How does Peramivir work?

Mechanism of Action Peramivir is an antiviral medicine classified as a neuraminidase inhibitor. It works by interfering with the way the influenza virus spreads within the respiratory system. When a person has the flu, the virus enters cells in the body to make copies of itself. To release these new virus particles so they can infect other healthy cells, the virus uses a specific enzyme called neuraminidase. Peramivir binds to this enzyme and blocks its activity. By inhibiting this enzyme, peramivir provides the following effects: Prevents Viral Release: The new virus particles remain trapped within the infected cells and cannot spread to neighboring cells. Slows Infection: Because the virus cannot spread as easily, the overall viral load in the body is reduced. Shortens Illness: By limiting the spread of the virus early on, the medication helps the immune system clear the infection faster, which can shorten the duration of flu symptoms. This medication is effective against both influenza A and influenza B. It does not kill the virus directly but prevents it from multiplying and spreading, which allows the body's natural defenses to work more effectively.

Q: What are the brand names for Peramivir?

Peramivir is sold under the brand name Rapivab .

Q: What are the active ingredients in Peramivir?

The active ingredient in Peramivir is peramivir .

Q: What are the side effects of Peramivir?

Common side effects of Peramivir may include: Diarrhea Nausea Vomiting Always consult with a healthcare professional about potential side effects.

Q: What drug class is Peramivir?

Peramivir belongs to the neuraminidase inhibitor drug class.

Q: What is the dosage of Peramivir and how do I take it?

Administration Peramivir is delivered directly into a vein through an intravenous (IV) infusion. This procedure is performed by a healthcare professional in a clinical setting, such as a hospital or doctor's office. The treatment is typically given as a single dose. The infusion process usually lasts for a short period of time to ensure the medication is delivered safely. Timing of Treatment This medication is most effective when started shortly after flu symptoms begin. It is generally recommended that the infusion be administered within the first two days of the onset of symptoms, such as fever, cough, or sore throat. Missed Dose Because peramivir is administered as a one-time dose by a medical professional, a missed dose is unlikely. If you miss an appointment for your infusion, contact your healthcare provider immediately to reschedule.

Q: What forms and strengths does Peramivir come in?

Peramivir is available in the following form: Intravenous Solution: A clear, colorless liquid supplied in single-use vials for administration into a vein. This medication is administered as an infusion (IV) by a doctor or nurse in a medical setting, such as a hospital or clinic.

Question 1

What is Peramivir?

Accepted Answer

Peramivir is an antiviral medication that belongs to a class of drugs known as neuraminidase inhibitors. It works by blocking an enzyme used by the influenza virus to spread from infected cells to healthy cells throughout the body.

By inhibiting this viral activity, the medication helps to limit the spread of the virus in the system. This process assists the body in managing the infection and reducing the severity of flu symptoms.

Question 2

What is Peramivir used for?

Accepted Answer

Peramivir is used to treat acute uncomplicated influenza.

Question 3

How does Peramivir work?

Accepted Answer

Mechanism of Action

Peramivir is an antiviral medicine classified as a neuraminidase inhibitor. It works by interfering with the way the influenza virus spreads within the respiratory system.

When a person has the flu, the virus enters cells in the body to make copies of itself. To release these new virus particles so they can infect other healthy cells, the virus uses a specific enzyme called neuraminidase. Peramivir binds to this enzyme and blocks its activity.

By inhibiting this enzyme, peramivir provides the following effects:

Prevents Viral Release: The new virus particles remain trapped within the infected cells and cannot spread to neighboring cells.
Slows Infection: Because the virus cannot spread as easily, the overall viral load in the body is reduced.
Shortens Illness: By limiting the spread of the virus early on, the medication helps the immune system clear the infection faster, which can shorten the duration of flu symptoms.

This medication is effective against both influenza A and influenza B. It does not kill the virus directly but prevents it from multiplying and spreading, which allows the body's natural defenses to work more effectively.

Question 4

What are the brand names for Peramivir?

Accepted Answer

Peramivir is sold under the brand name Rapivab.

Question 5

What are the active ingredients in Peramivir?

Accepted Answer

The active ingredient in Peramivir is peramivir.

Question 6

What are the side effects of Peramivir?

Accepted Answer

Common side effects of Peramivir may include:

Diarrhea
Nausea
Vomiting

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Peramivir?

Accepted Answer

Peramivir belongs to the neuraminidase inhibitor drug class.

Question 8

What is the dosage of Peramivir and how do I take it?

Accepted Answer

Administration

Peramivir is delivered directly into a vein through an intravenous (IV) infusion. This procedure is performed by a healthcare professional in a clinical setting, such as a hospital or doctor's office.

The treatment is typically given as a single dose. The infusion process usually lasts for a short period of time to ensure the medication is delivered safely.

Timing of Treatment

This medication is most effective when started shortly after flu symptoms begin. It is generally recommended that the infusion be administered within the first two days of the onset of symptoms, such as fever, cough, or sore throat.

Missed Dose

Because peramivir is administered as a one-time dose by a medical professional, a missed dose is unlikely. If you miss an appointment for your infusion, contact your healthcare provider immediately to reschedule.

Question 9

Is Peramivir safe during pregnancy and breastfeeding?

Accepted Answer

There are no adequate and well-controlled studies regarding the use of peramivir in pregnant women. It is currently unknown whether the drug can cause harm to a developing fetus or affect the ability to have children in the future.

Because pregnant women are at an increased risk for severe complications from influenza, healthcare providers may consider peramivir if the potential benefit to the mother justifies the potential risk to the fetus.

It is not known if peramivir is excreted in human breast milk. Because many medications can pass into breast milk, caution is recommended when peramivir is administered to someone who is nursing.

If you are pregnant, planning to become pregnant, or breastfeeding, discuss your treatment options and any concerns with your healthcare provider.

Question 10

What forms and strengths does Peramivir come in?

Accepted Answer

Peramivir is available in the following form:

Intravenous Solution: A clear, colorless liquid supplied in single-use vials for administration into a vein.

This medication is administered as an infusion (IV) by a doctor or nurse in a medical setting, such as a hospital or clinic.

Question 11

What is the FDA approval status of Peramivir?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved peramivir in December 2014. It is indicated for the treatment of acute uncomplicated influenza in patients 6 months of age and older who have been symptomatic for no more than two days. It is administered as a single intravenous dose by a healthcare provider.

Regulatory History and Scope

While originally approved for adults, the FDA expanded the indication to include pediatric patients aged 2 to 12 years in 2017, and later to infants as young as 6 months in 2021. The drug is not approved for the prevention of influenza or for the treatment of patients with complicated or chronic underlying medical conditions.

Safety Monitoring and Warnings

There are no boxed warnings for peramivir. However, the FDA requires monitoring for certain serious adverse reactions identified during postmarketing surveillance, including:

Neuropsychiatric Events: Patients with influenza, particularly children and adolescents, may be at an increased risk of seizures, confusion, or abnormal behavior.
Serious Skin Reactions: Rare but severe skin conditions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported.
Hypersensitivity: Severe allergic reactions, including anaphylaxis, can occur.

The FDA continues to monitor the safety profile of peramivir through postmarketing reports to ensure the benefits of the medication outweigh its risks.

Question 12

What should I know about Peramivir and fda approval?

Accepted Answer

Initial FDA Approval

The U.S. Food and Drug Administration (FDA) approved peramivir in December 2014. It was the first neuraminidase inhibitor available in an intravenous (IV) formulation for the treatment of acute uncomplicated influenza in adults 18 years and older. The approval was based on clinical trials showing that a single dose could reduce the duration of flu symptoms when administered early.

Expanded Use in Children

Following its initial approval for adults, the FDA expanded the authorized use of peramivir to younger populations:

2017: The FDA approved the medication for use in pediatric patients aged 2 to 17 years.
2021: The approval was further extended to include infants and children as young as 6 months of age.

Approved Indications and Timing

Peramivir is FDA-approved specifically for the treatment of acute uncomplicated influenza in patients who have been symptomatic for no more than two days. It is not approved for the prevention of the flu or for use in patients with serious influenza requiring hospitalization.

History of Emergency Use

Before its formal approval in 2014, peramivir was made available under an Emergency Use Authorization (EUA) during the 2009 H1N1 influenza pandemic. This allowed healthcare providers to use the drug for certain hospitalized patients before the full clinical review process for its current indication was completed.

Peramivir

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Peramivir

Hospitals.net Disclosure